It's been a long road for regenerative medicine pioneer Ocata Therapeutics Inc., founded in 1994 as Advanced Cell Technology Inc. (ACT), where one of its earliest deals was a $10 million collaboration with Genzyme Transgenics Corp. to create cloned cows capable of producing human serum albumin in their milk. (See BioWorld Today, Oct. 9, 1997.)